BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7729895)

  • 21. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Larbig M; Mansouri E; Freihorst J; Tümmler B; Köhler G; Domdey H; Knapp B; Hungerer KD; Hundt E; Gabelsberger J; von Specht BU
    Vaccine; 2001 Mar; 19(17-19):2291-7. PubMed ID: 11257350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on Construction of Recombinant Bb-pGEX-
    Liu X; Li WG; Luo GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections.
    von Specht BU; Gabelsberger J; Knapp B; Hundt E; Schmidt-Pilger H; Bauernsachs S; Lenz U; Domdey H
    J Biotechnol; 2000 Sep; 83(1-2):3-12. PubMed ID: 11000453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
    Knapp B; Hundt E; Lenz U; Hungerer KD; Gabelsberger J; Domdey H; Mansouri E; Li Y; von Specht BU
    Vaccine; 1999 Mar; 17(13-14):1663-6. PubMed ID: 10194820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
    Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
    J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
    Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
    Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
    Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of the major outer-membrane protein OprF from plant root-colonizing Pseudomonas fluorescens.
    De Mot R; Schoofs G; Roelandt A; Declerck P; Proost P; Van Damme J; Vanderleyden J
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1377-87. PubMed ID: 7521711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
    Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Yu X; Wang Y; Xia Y; Zhang L; Yang Q; Lei J
    Vaccine; 2016 Aug; 34(37):4399-405. PubMed ID: 27449680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preparation of Pseudomonas aeruginosa recombinant outer-membrane protein F and the study of its antigenic properties].
    Kaloshin AA; Zlygostev SA; Toropchina IuN; Kurbatova EA; Zverev VV; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):50-3. PubMed ID: 16279535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
    Worgall S; Krause A; Qiu J; Joh J; Hackett NR; Crystal RG
    J Virol; 2007 Dec; 81(24):13801-8. PubMed ID: 17942539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
    Haberstroh J; Gilleland HE; von Specht BU
    Eur Surg Res; 2005; 37(5):265-73. PubMed ID: 16374008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
    Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
    Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the length of a malarial epitope on its antigenicity and immunogenicity in an epitope presentation system using the Pseudomonas aeruginosa outer membrane protein OprF as the carrier.
    Wong RS; Hancock RE
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):209-14. PubMed ID: 8764483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.
    Peluso L; de Luca C; Bozza S; Leonardi A; Giovannini G; Lavorgna A; De Rosa G; Mascolo M; Ortega De Luna L; Catania MR; Romani L; Rossano F
    BMC Microbiol; 2010 Jan; 10():9. PubMed ID: 20070893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U; Göcke K; Gewecke B; Freihorst J; von Specht BU
    Respir Res; 2007 Aug; 8(1):57. PubMed ID: 17683588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.